These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24496898)

  • 21. Proton-Pump Inhibitors and Fragility Fractures in Vulnerable Older Patients.
    Zirk-Sadowski J; Masoli JA; Strain WD; Delgado J; Henley W; Hamilton W; Melzer D; Ble A
    Am J Gastroenterol; 2017 Mar; 112(3):520-523. PubMed ID: 28270664
    [No Abstract]   [Full Text] [Related]  

  • 22. Bone up on proton pump inhibitors and fracture risk.
    Gendreau-Webb R
    Nursing; 2007 Oct; 37(10):60-1. PubMed ID: 17906557
    [No Abstract]   [Full Text] [Related]  

  • 23. Proton pump inhibitors, fracture risk and selection bias: three studies, same database, two answers.
    de Vries F; van Staa TP; Leufkens HG
    Osteoporos Int; 2011 May; 22(5):1641-2. PubMed ID: 20563562
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study.
    Lewis JR; Barre D; Zhu K; Ivey KL; Lim EM; Hughes J; Prince RL
    J Bone Miner Res; 2014 Nov; 29(11):2489-97. PubMed ID: 24825180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Proton pump inhibitors: not as safe as they seem].
    van Herwaarden N; Bos JM; Veldman B; Kramers C
    Ned Tijdschr Geneeskd; 2016; 160():D487. PubMed ID: 27438396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of long-term PPI therapy.
    Reimer C
    Best Pract Res Clin Gastroenterol; 2013 Jun; 27(3):443-54. PubMed ID: 23998981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acid suppressants and hip fracture: duplicate publication bias?
    Bazelier M; de Boer A; de Vries F
    Bone; 2011 Oct; 49(4):920; author reply 921. PubMed ID: 21820528
    [No Abstract]   [Full Text] [Related]  

  • 29. Fracture risk with PPIs and allergy to IV contrast.
    Dedea L
    JAAPA; 2010 Aug; 23(8):13. PubMed ID: 20821906
    [No Abstract]   [Full Text] [Related]  

  • 30. PPIs: too much of a good thing?
    Drug Ther Bull; 2011 May; 49(5):49. PubMed ID: 21543370
    [No Abstract]   [Full Text] [Related]  

  • 31. A Proton Pump Inhibitor in the Reformulation Setting: Bioequivalence and Potential Implications for Long-Term Safety.
    Dubcenco E; Beers-Block PM; Kim LP; Schotland P; Levine JG; McCloskey CA; Bashaw ED
    Clin Transl Sci; 2017 Sep; 10(5):387-394. PubMed ID: 28618191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acid suppressants, fracture, and statistical adjustments for body mass index, smoking status, and calcium/vitamin D intake.
    de Vries F
    Am J Gastroenterol; 2011 Nov; 106(11):2051. PubMed ID: 22056590
    [No Abstract]   [Full Text] [Related]  

  • 33. Proton pump-inhibiting drugs, calcium homeostasis, and bone health.
    Wright MJ; Proctor DD; Insogna KL; Kerstetter JE
    Nutr Rev; 2008 Feb; 66(2):103-8. PubMed ID: 18254877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPIs and fracture risk.
    Med Lett Drugs Ther; 2013 Feb; 55(1410):15-6. PubMed ID: 23459458
    [No Abstract]   [Full Text] [Related]  

  • 35. Proton Pump Inhibitors and Fractures During Growth.
    Sugiyama T
    JAMA Pediatr; 2021 Feb; 175(2):208-209. PubMed ID: 32986077
    [No Abstract]   [Full Text] [Related]  

  • 36. [Emergent adverse effects of proton pump inhibitors].
    Bourne C; Charpiat B; Charhon N; Bertin C; Gouraud A; Mouchoux C; Skalli S; Janoly-Dumenil A
    Presse Med; 2013 Feb; 42(2):e53-62. PubMed ID: 23237784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton Pump Inhibitors and Fractures During Growth-Reply.
    Wang YH; Pasternak B
    JAMA Pediatr; 2021 Feb; 175(2):209-210. PubMed ID: 32986123
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.
    van der Hoorn MMC; Tett SE; de Vries OJ; Dobson AJ; Peeters GMEEG
    Bone; 2015 Dec; 81():675-682. PubMed ID: 26319499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse effects of proton pump inhibitors.
    Lodato F; Azzaroli F; Turco L; Mazzella N; Buonfiglioli F; Zoli M; Mazzella G
    Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):193-201. PubMed ID: 20227032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between proton pump inhibitors therapy and fracture risk in patients with rheumatoid arthritis.
    Lai SW; Kuo YH; Liao KF
    Ann Rheum Dis; 2020 Dec; 79(12):e156. PubMed ID: 31300456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.